Crossmark Global Holdings, Inc. Repligen Corp Transaction History

Crossmark Global Holdings, Inc.

  • $5.5 Billion
  • Q1 2025

A detailed history of Crossmark Global Holdings, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 4,108 shares of RGEN stock, worth $545,829. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,108
Previous 3,941 4.24%
Holding current value
$545,829
Previous $567,000 7.94%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025
BUY
$127.24 - $174.24 $21,249 - $29,098
167 Added 4.24%
4,108 $522,000
Q4 2024

Jan 16, 2025
SELL
$123.41 - $160.92 $15,673 - $20,436
-127 Reduced 3.12%
3,941 $567,000
Q3 2024

Nov 04, 2024
BUY
$119.79 - $167.35 $52,228 - $72,964
436 Added 12.0%
4,068 $606,000
Q2 2024

Jul 29, 2024
SELL
$120.0 - $182.95 $52,440 - $79,949
-437 Reduced 10.74%
3,632 $458,000
Q1 2024

May 13, 2024
BUY
$170.78 - $208.42 $45,085 - $55,022
264 Added 6.94%
4,069 $748,000
Q4 2023

Feb 13, 2024
SELL
$114.17 - $185.35 $36,420 - $59,126
-319 Reduced 7.74%
3,805 $684,000
Q3 2023

Nov 08, 2023
SELL
$138.78 - $176.51 $14,433 - $18,357
-104 Reduced 2.46%
4,124 $640,000
Q2 2023

Jul 31, 2023
SELL
$138.42 - $180.31 $48,031 - $62,567
-347 Reduced 7.58%
4,228 $737,000
Q1 2023

May 12, 2023
BUY
$154.26 - $198.1 $27,921 - $35,856
181 Added 4.12%
4,575 $770,000
Q4 2022

Jan 19, 2023
BUY
$162.42 - $220.56 $6,009 - $8,160
37 Added 0.85%
4,394 $744,000
Q3 2022

Nov 01, 2022
BUY
$160.42 - $256.21 $1,122 - $1,793
7 Added 0.16%
4,357 $815,000
Q2 2022

Jul 29, 2022
SELL
$140.68 - $188.02 $5,627 - $7,520
-40 Reduced 0.91%
4,350 $707,000
Q1 2022

May 11, 2022
SELL
$161.19 - $257.96 $53,192 - $85,126
-330 Reduced 6.99%
4,390 $826,000
Q4 2021

Jan 10, 2022
SELL
$247.59 - $304.47 $584,312 - $718,549
-2,360 Reduced 33.33%
4,720 $1.25 Million
Q3 2021

Oct 21, 2021
BUY
$194.77 - $324.21 $1.38 Million - $2.3 Million
7,080 New
7,080 $2.05 Million
Q3 2021

Oct 13, 2021
SELL
$194.77 - $324.21 $1.45 Million - $2.42 Million
-7,460 Closed
0 $0
Q2 2021

Jul 21, 2021
SELL
$165.87 - $220.95 $58,054 - $77,332
-350 Reduced 4.48%
7,460 $1.49 Million
Q1 2021

Apr 15, 2021
BUY
$180.37 - $226.26 $1,803 - $2,262
10 Added 0.13%
7,810 $1.52 Million
Q4 2020

Jan 14, 2021
BUY
$148.08 - $206.57 $65,155 - $90,890
440 Added 5.98%
7,800 $1.5 Million
Q3 2020

Oct 08, 2020
BUY
$122.51 - $158.27 $9,800 - $12,661
80 Added 1.1%
7,360 $1.09 Million
Q2 2020

Aug 14, 2020
BUY
$94.33 - $140.48 $80,180 - $119,407
850 Added 13.22%
7,280 $900,000
Q1 2020

Apr 28, 2020
SELL
$84.96 - $109.14 $3,398 - $4,365
-40 Reduced 0.62%
6,430 $620,000
Q4 2019

Feb 06, 2020
BUY
$73.84 - $93.08 $13,291 - $16,754
180 Added 2.86%
6,470 $598,000
Q3 2019

Oct 09, 2019
SELL
$76.65 - $95.51 $766 - $955
-10 Reduced 0.16%
6,290 $482,000
Q2 2019

Jul 09, 2019
SELL
$54.2 - $85.95 $9,756 - $15,471
-180 Reduced 2.78%
6,300 $541,000
Q1 2019

May 02, 2019
SELL
$49.45 - $62.8 $4,450 - $5,652
-90 Reduced 1.37%
6,480 $383,000
Q4 2018

Jan 31, 2019
SELL
$48.26 - $68.88 $188,696 - $269,320
-3,910 Reduced 37.31%
6,570 $347,000
Q3 2018

Nov 08, 2018
BUY
$46.8 - $58.97 $15,911 - $20,049
340 Added 3.35%
10,480 $581,000
Q2 2018

Jul 31, 2018
BUY
$35.26 - $47.04 $14,456 - $19,286
410 Added 4.21%
10,140 $477,000
Q1 2018

Apr 16, 2018
SELL
$30.92 - $37.27 $23,499 - $28,325
-760 Reduced 7.24%
9,730 $352,000
Q4 2017

Feb 05, 2018
BUY
$32.53 - $38.92 $136,300 - $163,074
4,190 Added 66.51%
10,490 $381,000
Q3 2016

Oct 25, 2017
BUY
N/A
6,300
6,300 $241,000

Others Institutions Holding RGEN

# of Institutions
495
Shares Held
57.6M
Call Options Held
75.6K
Put Options Held
521K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.37B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email